tivozanib could evaluated in combination regimens for renal cell carcinoma
Published 4 years ago • 140 plays • Length 1:15Download video MP4
Download video MP3
Similar videos
-
1:05
dr. pal on potential tivozanib-based combinations in rcc
-
12:49
the tivo-3 study of tivozanib in metastatic renal cell carcinoma
-
2:17
other trials and combinations to treat renal cell carcinoma
-
4:07
tivo-3 results point to tivozanib activity after rcc progression on axitinib | brian rini
-
51:09
immunotherapy-based combinations for advanced/metastatic renal cell carcinoma: asco gu 2023
-
2:06
dr. rini discusses tivozanib in advanced rcc
-
2:32
dr. robert motzer discusses the safety and efficacy of tivozanib in kidney cancer
-
1:14
combining immunotherapy with antiangiogenesis in rcc
-
1:28:18
navigating evolving standards of care in rcc: novel targeted and immunotherapy options
-
31:14
current treatment of advanced renal cell carcinoma, christian kollmannsberger, md
-
22:35
recent advance in tivozanib plus nivolumab combinatorial strategies in advanced renal cell carcinoma
-
0:54
advances in the development of targeted therapies for renal cell carcinoma
-
55:12
selecting and sequencing targeted and immunotherapy regimens for patients with rcc
-
39:34
immunotherapy in renal cell carcinoma
-
0:41
dr. toni choueiri on cabozantinib and nivolumab combination in kidney cancer
-
1:16:25
rcc masterclass and clinical consult: novel immune and targeted therapies
-
34:02
auau podcast: targeted therapies in renal cell carcinoma
-
29:11
new data and clinical context: an update on renal cell carcinoma care
-
1:42:57
live webinar on management of renal cell carcinoma in the new millennium